Cargando…

A simple method for discrimination of carcinomatous meningitis using CEA, total protein, and total cell count in the cerebrospinal fluid of primary lung cancer patients

Carcinomatous meningitis (CM) is a critical issue for physicians. However, no study has reported a simple and useful diagnostic or predictive marker for CM. This study aimed to elucidate the potential markers for diagnosing CM derived from cerebrospinal fluid (CSF). We retrospectively enrolled 78 lu...

Descripción completa

Detalles Bibliográficos
Autores principales: Ogawa, Yukari, Saraya, Takeshi, Noda, Akinari, Kurokawa, Nozomi, Sakuma, Sho, Aso, Kaori, Mikura, Sunao, Oda, Miku, Ishida, Manabu, Honda, Kojiro, Nakamoto, Keitaro, Tamura, Masaki, Takata, Saori, Ishii, Haruyuki, Takizawa, Hajime
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8036056/
https://www.ncbi.nlm.nih.gov/pubmed/33832119
http://dx.doi.org/10.1097/MD.0000000000025367
_version_ 1783676826062684160
author Ogawa, Yukari
Saraya, Takeshi
Noda, Akinari
Kurokawa, Nozomi
Sakuma, Sho
Aso, Kaori
Mikura, Sunao
Oda, Miku
Ishida, Manabu
Honda, Kojiro
Nakamoto, Keitaro
Tamura, Masaki
Takata, Saori
Ishii, Haruyuki
Takizawa, Hajime
author_facet Ogawa, Yukari
Saraya, Takeshi
Noda, Akinari
Kurokawa, Nozomi
Sakuma, Sho
Aso, Kaori
Mikura, Sunao
Oda, Miku
Ishida, Manabu
Honda, Kojiro
Nakamoto, Keitaro
Tamura, Masaki
Takata, Saori
Ishii, Haruyuki
Takizawa, Hajime
author_sort Ogawa, Yukari
collection PubMed
description Carcinomatous meningitis (CM) is a critical issue for physicians. However, no study has reported a simple and useful diagnostic or predictive marker for CM. This study aimed to elucidate the potential markers for diagnosing CM derived from cerebrospinal fluid (CSF). We retrospectively enrolled 78 lung cancer patients with suspected CM during the clinical course, including 42 CM and 36 non-CM patients. We compared the clinical and CSF findings, including carcinoembryonic antigen (CEA), between CM and non-CM patients, and explored the diagnostic markers for early identification of CM as well as the contributing factors for mortality. On CSF analysis, with cutoff values of CEA ≥5 ng/ml, total protein (TP) in CSF ≥45 g/dl, and total cell count (TCC) ≥7 cells/μL, the sensitivity, specificity, and area under the curve (AUC) for CM were 85.7%, 84.6%, and 0.887 (95% CI: 0.758–1.0, P < .001); 80.5%, 69.4%, and 0.755 (95% CI: 0.646–0.865, P < .001); and 56.1%, 100%, and 0.817 (95% CI: 0.722–0.912, P < .001), respectively. TP levels in CSF ≥the patients’ age had a sensitivity, specificity, and an AUC of 48.8%, 77.8%, and 0.633 (95% CI: 0.722–0.912, P = .045) for CM, respectively. Among CM patients, patients with ‘TP in CSF (>patients’ age)” (n = 19, P = .008) showed significantly shorter 90-day survival probability than the residual patients (n = 20). None of the CSF parameters could predict the risk of mortality on Cox regression analysis. The cutoff value of CEA ≥5 ng/ml in CSF is a simple and useful method with a high diagnostic value for CM diagnosis, but not a suitable predicting factor for mortality. ‘TP in CSF >patients’ age” might be a novel factor for assessing short-term mortality.
format Online
Article
Text
id pubmed-8036056
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-80360562021-04-13 A simple method for discrimination of carcinomatous meningitis using CEA, total protein, and total cell count in the cerebrospinal fluid of primary lung cancer patients Ogawa, Yukari Saraya, Takeshi Noda, Akinari Kurokawa, Nozomi Sakuma, Sho Aso, Kaori Mikura, Sunao Oda, Miku Ishida, Manabu Honda, Kojiro Nakamoto, Keitaro Tamura, Masaki Takata, Saori Ishii, Haruyuki Takizawa, Hajime Medicine (Baltimore) 6700 Carcinomatous meningitis (CM) is a critical issue for physicians. However, no study has reported a simple and useful diagnostic or predictive marker for CM. This study aimed to elucidate the potential markers for diagnosing CM derived from cerebrospinal fluid (CSF). We retrospectively enrolled 78 lung cancer patients with suspected CM during the clinical course, including 42 CM and 36 non-CM patients. We compared the clinical and CSF findings, including carcinoembryonic antigen (CEA), between CM and non-CM patients, and explored the diagnostic markers for early identification of CM as well as the contributing factors for mortality. On CSF analysis, with cutoff values of CEA ≥5 ng/ml, total protein (TP) in CSF ≥45 g/dl, and total cell count (TCC) ≥7 cells/μL, the sensitivity, specificity, and area under the curve (AUC) for CM were 85.7%, 84.6%, and 0.887 (95% CI: 0.758–1.0, P < .001); 80.5%, 69.4%, and 0.755 (95% CI: 0.646–0.865, P < .001); and 56.1%, 100%, and 0.817 (95% CI: 0.722–0.912, P < .001), respectively. TP levels in CSF ≥the patients’ age had a sensitivity, specificity, and an AUC of 48.8%, 77.8%, and 0.633 (95% CI: 0.722–0.912, P = .045) for CM, respectively. Among CM patients, patients with ‘TP in CSF (>patients’ age)” (n = 19, P = .008) showed significantly shorter 90-day survival probability than the residual patients (n = 20). None of the CSF parameters could predict the risk of mortality on Cox regression analysis. The cutoff value of CEA ≥5 ng/ml in CSF is a simple and useful method with a high diagnostic value for CM diagnosis, but not a suitable predicting factor for mortality. ‘TP in CSF >patients’ age” might be a novel factor for assessing short-term mortality. Lippincott Williams & Wilkins 2021-04-09 /pmc/articles/PMC8036056/ /pubmed/33832119 http://dx.doi.org/10.1097/MD.0000000000025367 Text en Copyright © 2021 the Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License 4.0 (CCBY), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. http://creativecommons.org/licenses/by/4.0 (https://creativecommons.org/licenses/by/4.0/)
spellingShingle 6700
Ogawa, Yukari
Saraya, Takeshi
Noda, Akinari
Kurokawa, Nozomi
Sakuma, Sho
Aso, Kaori
Mikura, Sunao
Oda, Miku
Ishida, Manabu
Honda, Kojiro
Nakamoto, Keitaro
Tamura, Masaki
Takata, Saori
Ishii, Haruyuki
Takizawa, Hajime
A simple method for discrimination of carcinomatous meningitis using CEA, total protein, and total cell count in the cerebrospinal fluid of primary lung cancer patients
title A simple method for discrimination of carcinomatous meningitis using CEA, total protein, and total cell count in the cerebrospinal fluid of primary lung cancer patients
title_full A simple method for discrimination of carcinomatous meningitis using CEA, total protein, and total cell count in the cerebrospinal fluid of primary lung cancer patients
title_fullStr A simple method for discrimination of carcinomatous meningitis using CEA, total protein, and total cell count in the cerebrospinal fluid of primary lung cancer patients
title_full_unstemmed A simple method for discrimination of carcinomatous meningitis using CEA, total protein, and total cell count in the cerebrospinal fluid of primary lung cancer patients
title_short A simple method for discrimination of carcinomatous meningitis using CEA, total protein, and total cell count in the cerebrospinal fluid of primary lung cancer patients
title_sort simple method for discrimination of carcinomatous meningitis using cea, total protein, and total cell count in the cerebrospinal fluid of primary lung cancer patients
topic 6700
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8036056/
https://www.ncbi.nlm.nih.gov/pubmed/33832119
http://dx.doi.org/10.1097/MD.0000000000025367
work_keys_str_mv AT ogawayukari asimplemethodfordiscriminationofcarcinomatousmeningitisusingceatotalproteinandtotalcellcountinthecerebrospinalfluidofprimarylungcancerpatients
AT sarayatakeshi asimplemethodfordiscriminationofcarcinomatousmeningitisusingceatotalproteinandtotalcellcountinthecerebrospinalfluidofprimarylungcancerpatients
AT nodaakinari asimplemethodfordiscriminationofcarcinomatousmeningitisusingceatotalproteinandtotalcellcountinthecerebrospinalfluidofprimarylungcancerpatients
AT kurokawanozomi asimplemethodfordiscriminationofcarcinomatousmeningitisusingceatotalproteinandtotalcellcountinthecerebrospinalfluidofprimarylungcancerpatients
AT sakumasho asimplemethodfordiscriminationofcarcinomatousmeningitisusingceatotalproteinandtotalcellcountinthecerebrospinalfluidofprimarylungcancerpatients
AT asokaori asimplemethodfordiscriminationofcarcinomatousmeningitisusingceatotalproteinandtotalcellcountinthecerebrospinalfluidofprimarylungcancerpatients
AT mikurasunao asimplemethodfordiscriminationofcarcinomatousmeningitisusingceatotalproteinandtotalcellcountinthecerebrospinalfluidofprimarylungcancerpatients
AT odamiku asimplemethodfordiscriminationofcarcinomatousmeningitisusingceatotalproteinandtotalcellcountinthecerebrospinalfluidofprimarylungcancerpatients
AT ishidamanabu asimplemethodfordiscriminationofcarcinomatousmeningitisusingceatotalproteinandtotalcellcountinthecerebrospinalfluidofprimarylungcancerpatients
AT hondakojiro asimplemethodfordiscriminationofcarcinomatousmeningitisusingceatotalproteinandtotalcellcountinthecerebrospinalfluidofprimarylungcancerpatients
AT nakamotokeitaro asimplemethodfordiscriminationofcarcinomatousmeningitisusingceatotalproteinandtotalcellcountinthecerebrospinalfluidofprimarylungcancerpatients
AT tamuramasaki asimplemethodfordiscriminationofcarcinomatousmeningitisusingceatotalproteinandtotalcellcountinthecerebrospinalfluidofprimarylungcancerpatients
AT takatasaori asimplemethodfordiscriminationofcarcinomatousmeningitisusingceatotalproteinandtotalcellcountinthecerebrospinalfluidofprimarylungcancerpatients
AT ishiiharuyuki asimplemethodfordiscriminationofcarcinomatousmeningitisusingceatotalproteinandtotalcellcountinthecerebrospinalfluidofprimarylungcancerpatients
AT takizawahajime asimplemethodfordiscriminationofcarcinomatousmeningitisusingceatotalproteinandtotalcellcountinthecerebrospinalfluidofprimarylungcancerpatients
AT ogawayukari simplemethodfordiscriminationofcarcinomatousmeningitisusingceatotalproteinandtotalcellcountinthecerebrospinalfluidofprimarylungcancerpatients
AT sarayatakeshi simplemethodfordiscriminationofcarcinomatousmeningitisusingceatotalproteinandtotalcellcountinthecerebrospinalfluidofprimarylungcancerpatients
AT nodaakinari simplemethodfordiscriminationofcarcinomatousmeningitisusingceatotalproteinandtotalcellcountinthecerebrospinalfluidofprimarylungcancerpatients
AT kurokawanozomi simplemethodfordiscriminationofcarcinomatousmeningitisusingceatotalproteinandtotalcellcountinthecerebrospinalfluidofprimarylungcancerpatients
AT sakumasho simplemethodfordiscriminationofcarcinomatousmeningitisusingceatotalproteinandtotalcellcountinthecerebrospinalfluidofprimarylungcancerpatients
AT asokaori simplemethodfordiscriminationofcarcinomatousmeningitisusingceatotalproteinandtotalcellcountinthecerebrospinalfluidofprimarylungcancerpatients
AT mikurasunao simplemethodfordiscriminationofcarcinomatousmeningitisusingceatotalproteinandtotalcellcountinthecerebrospinalfluidofprimarylungcancerpatients
AT odamiku simplemethodfordiscriminationofcarcinomatousmeningitisusingceatotalproteinandtotalcellcountinthecerebrospinalfluidofprimarylungcancerpatients
AT ishidamanabu simplemethodfordiscriminationofcarcinomatousmeningitisusingceatotalproteinandtotalcellcountinthecerebrospinalfluidofprimarylungcancerpatients
AT hondakojiro simplemethodfordiscriminationofcarcinomatousmeningitisusingceatotalproteinandtotalcellcountinthecerebrospinalfluidofprimarylungcancerpatients
AT nakamotokeitaro simplemethodfordiscriminationofcarcinomatousmeningitisusingceatotalproteinandtotalcellcountinthecerebrospinalfluidofprimarylungcancerpatients
AT tamuramasaki simplemethodfordiscriminationofcarcinomatousmeningitisusingceatotalproteinandtotalcellcountinthecerebrospinalfluidofprimarylungcancerpatients
AT takatasaori simplemethodfordiscriminationofcarcinomatousmeningitisusingceatotalproteinandtotalcellcountinthecerebrospinalfluidofprimarylungcancerpatients
AT ishiiharuyuki simplemethodfordiscriminationofcarcinomatousmeningitisusingceatotalproteinandtotalcellcountinthecerebrospinalfluidofprimarylungcancerpatients
AT takizawahajime simplemethodfordiscriminationofcarcinomatousmeningitisusingceatotalproteinandtotalcellcountinthecerebrospinalfluidofprimarylungcancerpatients